文献速递炎症性肠病

炎症性肠病与超过1500种共病的风险:一项疾病全景的诊断前和诊断后表型关联研究

Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association Study.
PubMed 文献 · Am J Gastroenterol · 2025-07-30

银屑病和反应性关节病等肠外表现风险在诊断前10年即升高,心脏代谢和神经心理疾病在诊断前后均升高,骨质疏松等治疗相关后遗症主要见于诊断后。

要点

  • IBD诊断前10年即与银屑病和反应性关节病等肠外表现风险升高相关。
  • 心脏代谢和神经心理疾病风险在IBD诊断前后均升高。
  • 骨质疏松等潜在治疗后遗症主要见于IBD诊断后。

核心结论

  • 研究结果表明IBD是一种多系统疾病,尤其在诊断前10年即可表现为代谢、免疫和神经心理疾病。
  • 通过国际比较,研究发现了这些结果具有普遍性的证据。
  • 具有病因学意义的疾病需要进一步研究。

研究设计与样本

  • 研究为基于人群和疾病全景的表型关联研究。
  • 研究分析了1583种共病,并校正了多重检验,结果用芬兰公开数据验证。

主要发现

  • 研究识别出312个显著关联,其中125个出现在诊断前。
  • 银屑病风险在IBD诊断前升高:克罗恩病OR为2.58(95%CI 2.00-3.31),溃疡性结肠炎OR为1.54(95%CI 1.26-1.88)。
  • 反应性关节病风险在IBD诊断前升高:克罗恩病OR为2.07(95%CI 1.42-2.96),溃疡性结肠炎OR为1.42(95%CI 1.08-1.84)。
  • 骨质疏松风险主要见于诊断后:克罗恩病HR为2.56(95%CI 2.30-2.86),溃疡性结肠炎HR为1.92(95%CI 1.79-2.07)。
  • 在克罗恩病和溃疡性结肠炎中,分别仅有15.7%(44/281)和11.4%(35/301)的共病在丹麦与芬兰之间存在异质性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inflammatory bowel disease (IBD) is associated with various extraintestinal manifestations. We aimed to identify comorbidities in IBD and the timing of their development to provide potentially useful insight into the associations with IBD. METHODS: We conducted a population and disease-wide phenomic association study in IBD, using >6 million International Classification of Diseases, Tenth Revision coded healthcare contacts from 10 years before and up-to 17 years after IBD diagnosis to investigate associations with 1,583 comorbidities. To explore diseases with potential etiological significance, we compared association in the prediagnostic and the postdiagnostic periods. We corrected also for multiple-testing. These estimates were validated with publicly available data from Finland. RESULTS: We identified 312 significant associations with 125 appearing before diagnosis. Risk of extraintestinal manifestations was increased up to 10 years before IBD diagnosis, such as psoriasis (OR CD : 2.58 95% confidence interval: [2.00-3.31]; OR UC : 1.54 [1.26-1.88]) and reactive arthropathies (OR CD : 2.07 [1.42-2.96]; OR UC : 1.42 [1.08-1.84]). Risk of cardiometabolic and neuropsychological disorders was increased both prediagnostically and postdiagnostically. Potential treatment sequelae, such as osteoporosis (HR CD : 2.56 [2.30-2.86]; HR UC : 1.92 [1.79-2.07]) were primarily seen postdiagnostically. In only 15.7% (44/281) and 11.4% (35/301) of comorbidities in Crohn's disease and ulcerative colitis, respectively, did we observe heterogeneity between Denmark and Finland. DISCUSSION: Findings demonstrate that IBD is a multisystemic disease, particularly manifesting with metabolic, immune, and neuropsychological disorders, up to 10 years before diagnosis. We find evidence for the generality of these findings with an international comparison. Diseases of etiological interest warrant further investigation.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ebert AC, Verstockt B, Bøgsted M, et al. Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association Study. Am J Gastroenterol. 2025. PMID: 40737000. doi:10.14309/ajg.0000000000003673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。